Optimizing method development for efficiency, throughput and data quality
Monday 6 October 2025
07:00 [PDT] 10:00 [EDT] 15:00 [BST]
Alternative time zones
Basic training of small molecule method development that can be used to provide high-quality, fit-for-purpose LC–MS/MS data.
If done poorly, small molecule LC–MS/MS methods will impact the quality, throughput and reputation of a laboratory. When done correctly, the method is durable, accurate, precise and optimized to fit the ethos of the laboratory. Minimizing the time and resources it takes to develop a good assay is vital for productivity but must be balanced with a fit-for-purpose attitude. In this webinar, you will learn the basic principles of developing a high-quality small molecule LC–MS/MS method.
- The components of a high-quality assay
- Optimizing mass spectrometer parameters
- Optimizing LC parameters
- Optimizing the extraction method
Who may this interest?
- Principal Scientist, Bioanalytical Sciences
- Associate Director, Bioanalytical Sciences
- Group Leader, Bioanalysis
- Study Director (CROs or Sponsor side)
- Scientist III/IV or Senior Scientist – Bioanalysis
- Manager, Bioanalytical Operations
- Director, Clinical Pharmacology
- Director, Pharmacokinetics / PK-PD Modeling
- Program Lead, Nonclinical Development
- Project Manager, Preclinical / Translational Sciences
- Head of Outsourcing or Vendor Management (when tied to preclinical/clinical bioanalytical work)
- Director, Translational Medicine
Chad Christianson
Analytical Development Manager
Alturas Analytics, Inc. (ID, USA)
Chad has over 24 years of related experience as an analytical scientist, with 20 years focused on bioanalysis at Alturas Analytics. This depth of experience in applied LC–MS/MS, LC–HRMS and GC–MS/MS, along with an education in chemical engineering, provides the backbone for productive and innovative science.
As Analytical Development Manager, Chad is responsible for supervision of the analytical method development team, supporting complex method development, new technology evaluation/implementation and providing technical oversight to clients across all therapeutic areas. His additional responsibilities include acting as Study Director/Principal Investigator on GLP and clinical Studies. Chad also provides oversight of the research program, including supervising the development of the internship/outreach/graduate programs, as well as overall production of Alturas publications and scientific outreach.
In association with:
